Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Glenn Braswell arrest

This article was originally published in The Tan Sheet

Executive Summary

California businessman convicted of fraud in 1983 in a case involving hair growth products and subsequently pardoned by former President Bill Clinton charged with tax evasion, IRS says. Braswell, 59, was arrested Jan. 13 following federal investigation of his business Gero Vita International, which sells dietary supplements such as Levelin prohormone alternative, ACF 223 anti-aging formula and MVP Male Virility Power sexual stamina enhancer. Braswell's marketing tactics were the subject of September 2001 hearing by the Senate Special Committee on Aging (1"The Tan Sheet" Sept. 17, 2001, p. 8)...

You may also be interested in...

Supplement Health Fraud International Cooperation Urged At Hearing

Improved international collaboration could aid in the fight against dietary supplement health fraud, Sen. Ron Wyden (D-Ore.) suggested at a Senate Special Committee on Aging hearing Sept. 10.

Roche/Genentech Keeps Commitment To External Cancer Innovation

Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.

US FDA Eases Changes For Certain Sterile Injectable Container Closure Materials

To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts